Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01)
Deadline: June 4, 2020
Amount: Application budgets may not exceed direct costs of $240,000 per fiscal year, maximum project period is 5 years
The goal of this Funding Opportunity Announcement (FOA) is to support the independence of physician-scientist (PS) early-stage investigator (PS-ESI) faculty committed to academic careers in heart, lung, and blood diseases, and sleep disorders (HLBS) research and related implementation science by providing adequate protected time to conduct high quality research and establish independent research careers. To assist in individual career development of the PS-ESI, these awards encourage host institutions to relieve administrative burdens and foster collaborations among established researchers and early stage investigator (ESI) physician scientists.
- FAQ found here
- Early Stage Investigators status policies here
- The RFA requires 40% effort dedicated to this research award
- NHLBI intends to commit total costs of $1,875,000 in FY2019, $3,750,000 in FY2020, $5,625,000 in FY2021, $5,625,000 in FY2022, $5,625,000 in FY2023, $3,750,000 in FY2024 and $1,875,000 in FY2025 to fund up to 5 new awards in FY 2019, 5 new awards in FY 2020 and 5 new awards in FY 2021.
- Clinical trial optional